The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators.
Open accessAbstract
BACKGROUND: In patients with heart failure, activation of the renin-angiotensin system is common and has been postulated to provide a stimulus for further left ventricular (LV) structural and functional derangement. We tested the hypothesis that chronic administration of the angiotensin converting enzyme (ACE) inhibitor enalapril prevents or reverses LV dilatation and systolic dysfunction among patients with depressed ejection fraction (EF) and symptomatic heart failure. METHODS AND RESULTS: We examined subsets of patients enrolled in the Treatment Trial of Studies of Left Ventricular Dysfunction (SOLVD). Fifty-six patients with mild to moderate heart failure underwent serial radionuclide ventriculograms, and 16 underwent serial left heart catheterizations, before and after randomization to enalapril (2.5-20 mg/day) or placebo. At 1 year, there were significant treatment differences in LV end-diastolic volume (EDV; p less than 0.01), end-systolic volume (ESV; p less than 0.005), and EF (p less than 0.05). These effects resulted from increases in EDV (mean +/- SD, 136 +/- 27 to 151 +/- 38 ml/m2) and ESV (103 +/- 24 to 116 +/- 24 ml/m2) in the placebo group and decreases in EDV (140 +/- 44 to 127 +/- 37 ml/m2) and ESV (106 +/- 42 to 93 +/- 37 ml/m2) in the enalapril group. Mean LVEF increased in enalapril patients from 0.25 +/- 0.07 to 0.29 +/- 0.08 (p less than 0.01). There was a significant treatment difference in LV end-diastolic pressure at 1 year (p less than 0.05), with changes paralleling those of EDV. The time constant of LV relaxation changed only in the placebo group (p less than 0.01 versus enalapril), increasing from 59.2 +/- 8.0 to 67.8 +/- 7.2 msec. Serial radionuclide studies over a period of 33 months showed increases in LV volumes only in the placebo group. Two weeks after withdrawal of enalapril, EDV and ESV increased to baseline levels but not to the higher levels observed with placebo. CONCLUSIONS: In patients with heart failure and reduced LVEF, chronic ACE inhibition with enalapril prevents progressive LV dilatation and systolic dysfunction (increased ESV). These effects probably result from a combination of altered remodeling and sustained reduction in preload and afterload.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,103
The natural history of idiopathic dilated cardiomyopathy
Fuster, V., Gersh, B. J., Giuliani, E. R., Tajik, A. J., Brandenburg, R. O., & Frye, R. L. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90534-8 · Cited by 943
Influence of chronic captopril therapy on the infarcted left ventricle of the rat.
Pfeffer, J. M., Pfeffer, M. A., & Braunwald, E. (1985) · Circulation Research · doi:10.1161/01.res.57.1.84 · Cited by 808
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion.
McKay, R. G., Pfeffer, M. A., Pasternak, R. C., Markis, J. E., Come, P. C., Nakao, S., Alderman, J. D., Ferguson, J. J., Safian, R. D., & Grossman, W. (1986) · Circulation · doi:10.1161/01.cir.74.4.693 · Cited by 731
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 730
Franciosa, J. A., Wilen, M., Ziesche, S., & Cohn, J. N. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80141-6 · Cited by 672
Captopril in heart failure. A double blind controlled trial.
Cleland, J. G., Dargie, H. J., Hodsman, G. P., Ball, S. G., Robertson, J. I., Morton, J. J., East, B. W., Robertson, I., Murray, G. D., & Gillen, G. (1984) · Heart · doi:10.1136/hrt.52.5.530 · Cited by 379
Fletcher, P. J., Pfeffer, J. M., Pfeffer, M. A., & Braunwald, E. (1981) · Circulation Research · doi:10.1161/01.res.49.3.618 · Cited by 362
Sharpe, N., Smith, H., Murphy, J., Greaves, S., Hart, H., & Gamble, G. (1991) · The Lancet · doi:10.1016/0140-6736(91)90202-z · Cited by 308
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
Authors/Task Force Members, Ryden, L., Standl, E., Bartnik, M., Van den Berghe, G., Betteridge, J., de Boer, M.-J., Cosentino, F., Jonsson, B., Laakso, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl260 · Cited by 1,647
Guidelines for the diagnosis and treatment of chronic heart failure
Remme, W. (2001) · European Heart Journal · doi:10.1053/euhj.2001.2783 · Cited by 1,592
Spinale, F. G. (2007) · Physiological Reviews · doi:10.1152/physrev.00012.2007 · Cited by 1,120
Yu, C.-M., Chau, E., Sanderson, J. E., Fan, K., Tang, M.-O., Fung, W.-H., Lin, H., Kong, S.-L., Lam, Y.-M., Hill, M. R. S., et al. (2002) · Circulation · doi:10.1161/hc0402.102623 · Cited by 1,110
Bellenger, N. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2011 · Cited by 1,040
Left Ventricular Remodeling in Heart Failure
Konstam, M. A., Kramer, D. G., Patel, A. R., Maron, M. S., & Udelson, J. E. (2011) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.10.008 · Cited by 765
Self-citationYu, C.-M., Bleeker, G. B., Fung, J. W.-H., Schalij, M. J., Zhang, Q., van der Wall, E. E., Chan, Y.-S., Kong, S.-L., & Bax, J. J. (2005) · Circulation · doi:10.1161/circulationaha.105.538272 · Cited by 705
Januzzi, J. L., Prescott, M. F., Butler, J., Felker, G. M., Maisel, A. S., McCague, K., Camacho, A., Piña, I. L., Rocha, R. A., Shah, A. M., et al. (2019) · JAMA · doi:10.1001/jama.2019.12821 · Cited by 634
Racial Differences in Incident Heart Failure among Young Adults
Bibbins-Domingo, K., Pletcher, M. J., Lin, F., Vittinghoff, E., Gardin, J. M., Arynchyn, A., Lewis, C. E., Williams, O. D., & Hulley, S. B. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807265 · Cited by 612
Hall, S. A., Cigarroa, C. G., Marcoux, L., Risser, R. C., Grayburn, P. A., & Eichhorn, E. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00543-y · Cited by 537
Shindler, D. M., Kostis, J. B., Yusuf, S., Quinones, M. A., Pitt, B., Stewart, D., Pinkett, T., Ghali, J. K., Wilson, A. C., & The SOLVD Investigators (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89163-1 · Cited by 516
Self-citationPennell, D. J. (2006) · Blood · doi:10.1182/blood-2005-07-2948 · Cited by 495
Kramer, D. G., Trikalinos, T. A., Kent, D. M., Antonopoulos, G. V., Konstam, M. A., & Udelson, J. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.011 · Cited by 492
Self-citationIschemic Mitral Regurgitation on the Threshold of a Solution: From Paradoxes to Unifying Concepts
Levine, R. A., & Schwammenthal, E. (2005) · Circulation · doi:10.1161/circulationaha.104.486720 · Cited by 485
Greenberg, B., Quinones, M. A., Koilpillai, C., Limacher, M., Shindler, D., Benedict, C., & Shelton, B. (1995) · Circulation · doi:10.1161/01.cir.91.10.2573 · Cited by 473
Eichhorn, E. J., & Bristow, M. R. (1996) · Circulation · doi:10.1161/01.cir.94.9.2285 · Cited by 468
Ypenburg, C., van Bommel, R. J., Borleffs, C. J. W., Bleeker, G. B., Boersma, E., Schalij, M. J., & Bax, J. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.032 · Cited by 444
Merlo, M., Pyxaras, S. A., Pinamonti, B., Barbati, G., Di Lenarda, A., & Sinagra, G. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.030 · Cited by 430
Haykowsky, M. J., Liang, Y., Pechter, D., Jones, L. W., McAlister, F. A., & Clark, A. M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.055 · Cited by 400
Rouleau, J. L., Pfeffer, M. A., Stewart, D. J., Isaac, D., Sestier, F., Kerut, E. K., Porter, C. B., Proulx, G., Qian, C., & Block, A. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02602-7 · Cited by 396
Self-citationAdherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey
Komajda, M., Lapuerta, P., Hermans, N., Gonzalez-Juanatey, J. R., van Veldhuisen, D. J., Erdmann, E., Tavazzi, L., Poole-Wilson, P., & Le Pen, C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi251 · Cited by 390
Cleland, J. G., Teerlink, J. R., Senior, R., Nifontov, E. M., Mc Murray, J. J., Lang, C. C., Tsyrlin, V. A., Greenberg, B. H., Mayet, J., Francis, D. P., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61126-4 · Cited by 333
The Management of Chronic Heart Failure
Cohn, J. N. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350707 · Cited by 330
Spinale, F. G., Coker, M. L., Krombach, S. R., Mukherjee, R., Hallak, H., Houck, W. V., Clair, M. J., Kribbs, S. B., Johnson, L. L., Peterson, J. T., et al. (1999) · Circulation Research · doi:10.1161/01.res.85.4.364 · Cited by 323
Konstam, M. A., Kronenberg, M. W., Rousseau, M. F., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., & Kinan, D. (1993) · Circulation · doi:10.1161/01.cir.88.5.2277 · Cited by 316
Self-citationHeart Failure With Recovered Ejection Fraction: Clinical Description, Biomarkers, and Outcomes
Basuray, A., French, B., Ky, B., Vorovich, E., Olt, C., Sweitzer, N. K., Cappola, T. P., & Fang, J. C. (2014) · Circulation · doi:10.1161/circulationaha.113.006855 · Cited by 315
Zisman, L. S., Keller, R. S., Weaver, B., Lin, Q., Speth, R., Bristow, M. R., & Canver, C. C. (2003) · Circulation · doi:10.1161/01.cir.0000094734.67990.99 · Cited by 308
Domanski, M. J., Exner, D. V., Borkowf, C. B., Geller, N. L., Rosenberg, Y., & Pfeffer, M. A. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00609-3 · Cited by 301
Structural Basis for Heart Failure: Ventricular Remodeling and Its Pharmacological Inhibition
Cohn, J. N. (1995) · Circulation · doi:10.1161/01.cir.91.10.2504 · Cited by 297
Fallick, C., Sobotka, P. A., & Dunlap, M. E. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.961789 · Cited by 296
Quiñones, M. A., Greenberg, B. H., Kopelen, H. A., Koilpillai, C., Limacher, M. C., Shindler, D. M., Shelton, B. J., & Weiner, D. H. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00511-8 · Cited by 276
Mangiafico, S., Costello-Boerrigter, L. C., Andersen, I. A., Cataliotti, A., & Burnett, J. C. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs262 · Cited by 276
Angiotensin Receptors and Their Therapeutic Implications
Greindling, K. K., Lassegue, B., & Alexander, R. W. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001433 · Cited by 262
Molecular mechanisms of arrhythmogenic cardiomyopathy
Austin, K. M., Trembley, M. A., Chandler, S. F., Sanders, S. P., Saffitz, J. E., Abrams, D. J., & Pu, W. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0200-7 · Cited by 262
National Patterns of Angiotensin-Converting Enzyme Inhibitor Use in Congestive Heart Failure
Stafford, R. S. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420092008 · Cited by 156
Myocardial infarction and heart failure in the db/db diabetic mouse
Greer, J. J. M., Ware, D. P., & Lefer, D. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00583.2005 · Cited by 108
Sung, M. M., Das, S. K., Levasseur, J., Byrne, N. J., Fung, D., Kim, T. T., Masson, G., Boisvenue, J., Soltys, C.-L., Oudit, G. Y., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001677 · Cited by 102
Cesari, M., Pedone, C., Antonelli Incalzi, R., & Pahor, M. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2009.09.014 · Cited by 67
Krombach, R. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00050-9 · Cited by 40
Correale, M., Mazzeo, P., Tricarico, L., Croella, F., Fortunato, M., Magnesa, M., Amatruda, M., Alfieri, S., Ferrara, S., Ceci, V., et al. (2022) · Clinical Drug Investigation · doi:10.1007/s40261-022-01166-2 · Cited by 14
Physiologic expansion of human heart-derived cells enhances therapeutic repair of injured myocardium
Mount, S., Kanda, P., Parent, S., Khan, S., Michie, C., Davila, L., Chan, V., Davies, R. A., Haddad, H., Courtman, D., et al. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1418-3 · Cited by 12
Self-citation
Metadata
- Authors
- Konstam, M. A., Rousseau, M. F., Kronenberg, M. W., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., & Kinan, D.
- Venue
- Circulation
- Published
- 1992-08
- Volume
- 86
- Issue
- 2
- Pages
- 431-438
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1986644699
- Cited by
- 601
- References
- 19
- FWCI
- 22.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.